FDA approves Merck’s DIFICID to treat Clostridioides difficile in children aged six months and older
DIFICID is a macrolide antibacterial medicine indicated in adults and pediatric patients aged 6 months and older for treatment of CDAD. To reduce the development of drug-resistant bacteria